Other states can draw lessons from 2019 HCA deal, could give AGs more power to regulate sales, strengthen certificate-of-need laws, it notes.

PEDMARQSI is the First and Only Approved Therapy in the EU and U.K. for the Prevention of Ototoxicity, or Hearing Loss, Induced by Cisplatin Chemotherapy in Patients 1 month to ~ Norgine Pharmaceutica ...

One person died after a shooting in Brussels that was likely linked to clashes between rival drug gangs, the local prosecutor ...

PetSafe® has protected over 11 million dogs from harm, and it is our mission to unleash fields of joy for pets and their ...

The results were presented at the 2025 American Society of Clinical Oncology Gastrointestinal Cancers Symposium held in San Francisco late last month. They were also published in the Journal of ...

Newronika, the developer of groundbreaking adaptive deep brain stimulation technology, is proud to announce the receipt of an ...

FY25 Bookings of $242.4 million; book-to-bill ratio of 1.09Record backlog of $1.4 billion; up 6% year-over-yearQ2 FY25 Revenue of $223.1 million; GAAP net loss of $17.6 million; and adjusted EBITDA ...

Navega Therapeutics, a biotechnology company developing epigenetic gene therapies, today announced the receipt of a $4M Translational Science grant from CIRM for the relief of neuropathic pain.

As we celebrate Black History Month, we celebrate a woman who turned her passion for community empowerment into ...

The Cedar Falls High School Rocket Club is preparing to compete in the NASA Student Launch Challenge again and will showcase ...